Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07451613
PHASE1/PHASE2
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Sponsor: Leslie Thompson
View on ClinicalTrials.gov
Summary
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Official title: Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
21
Start Date
2026-03
Completion Date
2031-01
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
hNSC-01
neural stem cell therapy
Locations (1)
University of California, Irvine
Irvine, California, United States